Patent application number | Description | Published |
20090285895 | Pharmaceutical Formulation for Regulating the Timed Release of Biologically Active Compounds Based on a Polymer Matrix - A formulation containing a biologically active compound having a structure with hydrogen bonding sites is blended with a polymer having a structure with complementary hydrogen bonding sites, the polymer forming hydrolytic degradation products that promote the release of the biologically active compound from the polymer. | 11-19-2009 |
20110256206 | IMPLANTABLE DEVICES FOR TREATING HIV - The present invention relates to an implantable device comprising a biocompatible, biodegradable polymer mixed with TMC278 and with one or more release-enhancing agents selected from the group consisting of poloxamers, polysorbates, and a combination of dimethyl sulfoxide (DMSO) and poly(vinyl pyrrolidone)(PVP). | 10-20-2011 |
20120148678 | SUSTAINED RELEASE OF POORLY WATER SOLUBLE ACTIVE COMPOUNDS - We have disclosed an implantable sustained release composition comprising, a biocompatible, biodegradable polymer, a cyclodextrin inclusion complex of a poorly water soluble pharmaceutical agent present, and a plasticizer, where the polymer is the minority phase of the formulation. Furthermore, The we disclose an implantable sustained release composition that provides a detectable plasma level of an otherwise poorly soluble drug for at least 28 days. | 06-14-2012 |
20120277690 | DEGRADABLE REMOVABLE IMPLANT FOR THE SUSTAINED RELEASE OF AN ACTIVE COMPOUND - A degradable, removable, pharmaceutical implant for the sustained release of one or more drugs in a subject, wherein the pharmaceutical implant is composed of a tube comprising an outer wall made of a degradable polymer completely surrounding a cavity, wherein the outer wall has a plurality of openings and wherein the cavity contains one or more sets of micro-particles, which micro-particles contain an active agent or a combination of two or more active agents, and wherein the size of the microparticles is selected such that the majority of the microparticles cannot pass through the openings. | 11-01-2012 |
20140296799 | Degradable Removable Implant for the Sustained Release of An Active Compound - A degradable, removable, pharmaceutical implant for the sustained release of one or more drugs in a subject, wherein the pharmaceutical implant is composed of a tube comprising an outer wall made of a degradable polymer completely surrounding a cavity, wherein the outer wall has a plurality of openings and wherein the cavity contains one or more sets of micro-particles, which micro-particles contain an active agent or a combination of two or more active agents, and wherein the size of the microparticles is selected such that the majority of the microparticles cannot pass through the openings. | 10-02-2014 |
Patent application number | Description | Published |
20100299195 | SYSTEMS AND METHODS FOR IMPLEMENTING FINANCIAL TRANSACTIONS - A payment processing system to provide merchant-specific accounts to consumers that are accessed by payment instruments. In one embodiment, the payment processing system can create and provide a variety of payment methodologies for purchases, such as pay-as-you-go, virtual prepaid, virtual subscription, and post-paid purchases. The merchant may, in some embodiments provide consumers with merchant rewards accounts and an opportunity to earn reward points or other loyalty-based currencies through qualifying purchase transactions. The consumer may access their merchant-specific accounts for purchase payment using a preferred payment instrument, such as a credit or debit card. | 11-25-2010 |
20120185312 | SYSTEMS AND METHODS FOR IMPLEMENTING FINANCIAL TRANSACTIONS - A payment processing system to provide merchant-specific accounts to consumers that are accessed by payment instruments. In one embodiment, the payment processing system can create and provide a variety of payment methodologies for purchases, such as pay-as-you-go, virtual prepaid, virtual subscription, and post-paid purchases. The merchant may, in some embodiments provide consumers with merchant rewards accounts and an opportunity to earn reward points or other loyalty-based currencies through qualifying purchase transactions. The consumer may access their merchant-specific accounts for purchase payment using a preferred payment instrument, such as a credit or debit card. | 07-19-2012 |
20130266127 | SYSTEM AND METHOD FOR REMOVING SENSITIVE DATA FROM A RECORDING - Systems and methods for, among other things, removing sensitive data from an recording. The method, in certain embodiments, includes receiving an audio recording of a call and a text transcription of the audio recording, identifying events which occur during the call by detecting characteristic audio patterns in the audio recording and selected keywords and phrases in the text transcription, determining, from the identified events, a first event which precedes sensitive data in the call and a second event which occurs after sensitive data in the call, determining a portion of the call containing sensitive data with a start time at the first event and an end time at the second event, and removing the portion of the call between the start time and end time from the audio recording. | 10-10-2013 |
Patent application number | Description | Published |
20100275994 | SPECTRUM MANIPULATION DEVICE AND METHOD - A spectrum manipulation device and method for increasing an energy conversion efficiency of a photovoltaic cell arrangement, the device including: (a) a black body adapted to absorb an input electromagnetic energy having an input energy flux spectrum, and to emit a first output electromagnetic energy having a different, output energy flux spectrum; (b) a transparent cover, adapted to thermally insulate the black body from an ambient environment, and to receive light and direct the light towards the black body; (c) an optical device, facing the black body, and adapted to: (i) receive the first output energy and emit a second output electromagnetic energy having a narrow, modified energy flux spectrum, with respect to the output energy flux spectrum, and (ii) recycle some of the first output electromagnetic energy to the black body; (d) a photovoltaic cell having a photon absorption surface, disposed to be in optical communication with the optical device, and (e) a housing containing the black body and the optical device, and adapted to thermally insulate the black body and to fix a position of the black body with respect to the optical device, the optical device further adapted to direct the second output energy towards the photon absorption surface. | 11-04-2010 |
20100276000 | SOLAR ENERGY CONVERSION DEVICE AND METHOD - A device and method for producing electricity by harnessing sunlight to produce an amplified voltage signal, the device including: (a) a sealed chamber, defined by a transparent housing; (b) an excitable medium, disposed within the chamber, in which, when the medium is exposed to solar light having wavelengths in a range of 0.2 to 3 micrometers, bound electrons in the excitable medium are elevated to at least one higher energy state; (c) electrodes, disposed in a spaced apart fashion, whereby the medium is between, and fluidly communicates with, the electrodes; (d) an electric circuit, the medium and the electrodes completing the circuit; (e) an initiating mechanism, adapted to initiate an initial voltage signal through the chamber, between the electrodes, and (f) a power source, associated with the circuit, and adapted to maintain the first voltage signal through the chamber, between the electrodes, whereby the bound electrons in the higher energy state transfer energy to free electrons traversing the first voltage signal to produce the amplified voltage signal, and wherein the excitable medium is selected, and adapted within the chamber, to absorb at least 5% of an energy flux within a wavelength range of 0.2 to 3 micrometers, emitted by a black body operating at 5500K, by elevating the bound electrons to the higher energy state. | 11-04-2010 |
20150040980 | SPECTRUM MANIPULATION DEVICE AND METHOD - A spectrum manipulation device and method for increasing an energy conversion efficiency of a photovoltaic cell arrangement, the device including: (a) a black body adapted to absorb an input electromagnetic energy having an input energy flux spectrum, and to emit a first output electromagnetic energy having a different, output energy flux spectrum; (b) a transparent cover, adapted to thermally insulate the black body from an ambient environment, and to receive light and direct the light towards the black body; (c) an optical device, facing the black body, and adapted to: (i) receive the first output energy and emit a second output electromagnetic energy having a narrow, modified energy flux spectrum, with respect to the output energy flux spectrum, and (ii) recycle some of the first output electromagnetic energy to the black body; (d) a photovoltaic cell having a photon absorption surface, disposed to be in optical communication with the optical device, and (e) a housing containing the black body and the optical device, and adapted to thermally insulate the black body and to fix a position of the black body with respect to the optical device, the optical device further adapted to direct the second output energy towards the photon absorption surface. | 02-12-2015 |
Patent application number | Description | Published |
20100234416 | USE OF HUPERZINE FOR DISORDERS - Methods and compositions containing huperzine are used to prevent and alleviate neuropathic pain. The invention is also directed to methods and compositions for using huperzine for the prevention and/or treatment of neuropathic pain and orthostatic hypotension. | 09-16-2010 |
20110224245 | Treatment Of Neurological Disorders Using Huperzine - Methods and compositions containing huperzine for direct delivery to central nervous system (CNS) tissue are used to alleviate pain and for the prevention and/or treatment of seizures and epilepsy. The invention is also directed to methods and compositions for using huperzine for the prevention and/or treatment of neuropathic pain and orthostatic hypotension. | 09-15-2011 |
20110257517 | Patient-Specific Seizure Onset Detection System - The present invention provides methods and systems for patient-specific seizure onset detection. In one embodiment, at least one EEG waveform of the patient is recorded, and at least one epoch (sample) of the waveform is extracted. The waveform sample is decomposed into one or more subband signals via a wavelet decomposition of the waveform sample, and one or more feature vectors are computed based on the subband signals. A seizure onset can then be identified based on classification of the feature vectors to a seizure or a non-seizure class by comparing the feature vectors with a decision measure previously computed for that patient. The decision measure can be derived based on reference seizure and non-seizure EEG waveforms of the patient. In another aspect, similar methodology is employed for automatic detection of alpha waves. In other aspects, the invention provides diagnostic and imaging systems that incorporate the above seizure-onset and alpha-wave detection methodology. | 10-20-2011 |
20120107392 | USE OF HUPERZINE FOR DISORDERS - Methods and compositions containing huperzine are used to prevent and alleviate seizures. The invention is also directed to methods and compositions for using huperzine for the prevention and/or treatment of orthostatic hypotension. | 05-03-2012 |
20130136811 | Compositions and Methods for Pain Reduction - Compositions containing four-herb extract combination or Wogonin are useful in methods for the reduction of pain. A four-herb combination is used to treat pain as well as reduce or prevent epileptic seizures. | 05-30-2013 |